MAPS MDMA phase 3 trial update: Looking GOOD!
Added 2020-05-12 21:47:19 +0000 UTC"PTSD affects millions—and soon to be millions more—due to the global trauma of the COVID-19 pandemic. This includes victims of the disease and their families, health care and emergency service professionals, as well as front-line workers who are risking their lives to provide essential services.
"Psychedelic medicines show incredible promise for treating a range of mental health conditions, but psychedelic research has been underfunded for decades,” says Joe Green, Co-Founder and President of PSFC. “This first look at data from the first-ever Phase 3 trial of a psychedelic-assisted therapy only makes us more confident that we’re standing on the cusp of a breakthrough
"In the pharmaceutical drug development community, this is what you dream about,” says Rick Doblin, Ph.D., MAPS Founder and Executive Director. “The results of the interim analysis of MAPS’ pivotal first Phase 3 trial are the most powerful evidence yet that MDMA-assisted psychotherapy could help transform the lives of people suffering from PTSD. We have trained approximately 70 new therapists to work on Phase 3, so these results also show that the treatment is scalable, eventually to tens of thousands of therapists worldwide.”
Comments
I work almost exclusively with homeless veterans that suffer from PTSD having experienced it myself before they understood it to be a syndrome in 1973. If you do not understand PTSD you should not offer any help to those that do suffer from it. Most are right on the edge of a cliff called suicide anyway so it only takes a wrong word to make them do it. I pray MDMA is an answer because we are losing too many of our hero's to suicide that the VA denies.
Manofmars
2020-10-10 18:43:07 +0000 UTCI have personally experienced MDMA-assisted psychotherapy for PTSD and can say the treatment was very effective for me.
JenKin
2020-06-18 09:51:16 +0000 UTC
